Radiopharm Theranostics Limited Sponsored ADR(RADX)
$0.82-0.02 (-2.73%)
RADX
Radiopharm Theranostics Limited Sponsored ADR Revenue
$0.82
At close:-0.02 (-2.73%)
Want to see RADX full AI Analyst Report?
Radiopharm Theranostics Limited Sponsored ADR (RADX) Revenue
65 Followers
Radiopharm Theranostics Limited Sponsored ADR Revenue
Radiopharm Theranostics Limited Sponsored ADR had a revenue of 1.40M in the quarter ending Jun 30, 2025, with 3.07%. This bring the company's revenue in the last twelve months to 2.76M, Increased 103.07%. In the fiscal year ending Jun 30, 2025, Radiopharm Theranostics Limited Sponsored ADR had annual revenue of 2.71M with -25.49% growth.
- Revenue (ttm)
- 2.76M
- Revenue Growth
- -19.76%
- P/S Ratio
- 4.77
- Revenue/Employee
- $193,386
- Employees
- 14
- Market Cap
- $12.91M
Revenue Chart
Radiopharm Theranostics Limited Sponsored ADR Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.71M | -926.02K | -25.49% |
| Jun 30, 2024 | 3.63M | 3.33M | 1114.27% |
| Jun 30, 2023 | 299.23K | 6.87K | 2.35% |
| Jun 30, 2022 | 292.36K | 283.53K | 3210.60% |
| Jun 30, 2022 | 8.83K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.